Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2011 | 11-2010 | 08-2010 | 05-2010 | 02-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 744 | 98 | 412 | 701 | 987 |
| Other current assets | 2,593 | 0 | 8 | 1,824 | 100 |
| TOTAL | $3,354 | $132 | $437 | $2,544 | $1,115 |
| Non-Current Assets | |||||
| PPE Net | 6 | 7 | 7 | 4 | 4 |
| Other Non-Current Assets | 15 | 20 | 22 | 24 | 26 |
| TOTAL | $21 | $27 | $29 | $28 | $30 |
| Total Assets | $3,375 | $159 | $465 | $2,572 | $1,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 149 | 149 | 154 | 154 | 194 |
| Accounts payable and accrued liabilities | 524 | 272 | 192 | 205 | 290 |
| Accrued Expenses | 1,723 | 13 | 10 | 1,195 | 78 |
| Other current liabilities | 5,440 | N/A | N/A | 3,997 | N/A |
| TOTAL | $7,836 | $435 | $356 | $5,551 | $575 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7 | 7 | 7 | 236 | 236 |
| TOTAL | $7 | $7 | $7 | $236 | $236 |
| Total Liabilities | $7,843 | $442 | $363 | $5,787 | $811 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,757 | 21,371 | 20,952 | 20,942 | 20,574 |
| Common Shares | 9,112 | 7,940 | 7,342 | 7,145 | 6,855 |
| Retained earnings | -15,854 | -15,535 | -14,478 | -13,241 | -11,882 |
| Other shareholders' equity | -3,672 | 1,618 | 1,759 | -2,137 | 1,802 |
| TOTAL | $-4,468 | $-283 | $102 | $-3,216 | $334 |
| Total Liabilities And Equity | $3,375 | $159 | $465 | $2,572 | $1,145 |